cannot GET https://askwonder.com/api/v1/project_strategy/overview-corporate-priorities-abbott-recent-business-marketing-events-had-quotes-h38vcffif/scopes (401)

Abbott Laboratories

Goals

To provide the following information on Abbott Labs: an overview of its corporate priorities, recent business and marketing events, quotes from its business and marketing leadership, and links to news articles on the company.

Early Findings

News Articles on Abbott Labs

  • U.S. Approves Abbott Labs Five-Minute ‘Rapid’ Coronavirus Test: This news article by Forbes reports the US FDA's approval of Abbott Labs' "molecular test for the Coronavirus strain COVID-19," capable of delivering “positive results in as little as five minutes and negative results in 13 minutes.”
  • Abbott And Insulet Partner To Integrate Next-Generation Glucose Sensing And Automated Insulin Delivery Technologies For Seamless Diabetes Care: Abbott and Insulet Corporation have gone into a partnership "to integrate Abbott's world-leading1 glucose sensing technology with Insulet's next-generation tubeless system, the Omnipod Horizon™ Automated Insulin Delivery (AID) System (Omnipod Horizon System)."
  • Abbott Labs CEO on new coronavirus test launches: ‘There’s a need for more’: This news article by CNBC reports Abbott Labs' CEO, Miles White's interview with Jim Cramer. The FDA in March approved both of the COVID-19 test kits produced by Abbott, ID NOW COVID-19 and m2000 RealTime SARS-CoV-2.
  • Abbott Aims To Optimize Tavi Implants With European Approval Of Flexnav™ Delivery System For The Company's Portico™ Valve: Abbott recently announced that it has received the "CE Mark for the new FlexNav™ delivery system for the company's Portico™ transcatheter aortic valve implantation (TAVI) system."
  • Ride Abbott To $100 With Its New COVID-19 Test?: This news article by Forbes reports Abbott Labs' growth during the COVID-19 pandemic. The company's valuation is expected to increase "20% from the current levels."
  • Abbott Introduces Next-Generation Heart Rhythm Management Devices In Europe, Featuring State-Of-The-Art Patient App And Bluetooth Connectivity: Abbott Labs in February 2020 announced that it has received "CE Mark for the new Gallant™ implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices."
  • Abbott Shipping 150,000 Coronavirus Tests: This news article was published by Morning Star. Abbott Labs is currently shipping "150,000 Abbott RealTime SARS-CoV-2 EUA tests to existing customers in the U.S. The tests are used on Abbott's m2000 RealTime System." The company is "ramping up production" to provide "up to 1 million tests per week."
  • Abbott's Freestyle® Libre 14 Day System Now Available In U.S. For Hospitalized Patients With Diabetes During COVID-19 Pandemic: In April 2020, Abbott announced that "the FreeStyle Libre 14 day system, the world's leading3 continuous glucose monitoring (CGM) technology, can now be used in the hospital setting during the COVID-19 pandemic."

Proposed next steps:

You need to be the project owner to select a next step.